What is Zacks Research’s Forecast for Itron FY2027 Earnings?

Itron, Inc. (NASDAQ:ITRI – Free Report) – Stock analysts at Zacks Research lowered their FY2027 earnings per share (EPS) estimates for shares of Itron in a research note issued to investors on Thursday, October 22nd. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will post earnings per share of $5.89 for the year, down from their previous estimate of $5.90. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.41 per share.

Itron (NASDAQ:ITRI – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.30. The company had revenue of $562.90 million for the quarter, compared to the consensus estimate of $566.34 million. Itron had a return on equity of 19.26% and a net margin of 11.90%. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.62 EPS.

Other equities research analysts have also recently issued reports about the stock. Seaport Research Partners reiterated a “buy” rating and issued a $150.00 price target on shares of Itron in a research report on Wednesday, July 29th. Weiss Ratings raised shares of Itron from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, October 12th. Robert W. Baird set a $125.00 price objective on shares of Itron in a research report on Wednesday, July 29th. Finally, Needham & Company LLC lifted their price objective on shares of Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a research note on Wednesday, July 29th. Eight investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Itron presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.33.

Get Our Latest Research Report on ITRI

Itron Trading Up 0.1%

Shares of ITRI stock opened at $87.73 on Monday. The stock has a 50-day simple moving average of $91.38 and a 200 day simple moving average of $91.12. Itron has a fifty-two week low of $77.77 and a fifty-two week high of $142.00. The stock has a market capitalization of $3.84 billion, a P/E ratio of 14.65, a P/E/G ratio of 1.05 and a beta of 1.32. The company has a quick ratio of 2.29, a current ratio of 2.75 and a debt-to-equity ratio of 0.96.

Insider Activity

In other news, SVP John F. Marcolini sold 331 shares of Itron stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $98.79, for a total value of $32,699.49. Following the transaction, the senior vice president directly owned 12,683 shares of the company’s stock, valued at $1,252,953.57. This trade represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald Reeves, III sold 329 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $98.79, for a total transaction of $32,501.91. Following the sale, the senior vice president owned 27,945 shares in the company, valued at $2,760,686.55. This represents a 1.16% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 17,903 shares of company stock valued at $1,753,521. 1.77% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Itron

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its holdings in shares of Itron by 20.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock valued at $137,659,000 after purchasing an additional 265,039 shares in the last quarter. First Trust Advisors LP boosted its position in shares of Itron by 22.2% in the first quarter. First Trust Advisors LP now owns 969,228 shares of the scientific and technical instruments company’s stock worth $86,872,000 after buying an additional 176,053 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of Itron by 12.2% during the first quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after buying an additional 73,020 shares in the last quarter. Jupiter Topco LLC purchased a new position in shares of Itron during the second quarter valued at $42,466,000. Finally, Renaissance Technologies LLC grew its holdings in shares of Itron by 10.1% during the first quarter. Renaissance Technologies LLC now owns 461,761 shares of the scientific and technical instruments company’s stock valued at $41,388,000 after buying an additional 42,300 shares in the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.

Itron Company Profile

(Get Free Report)

Itron, Inc is a technology company that provides solutions to utilities and cities for managing electricity, natural gas, and water resources. Its offerings help organizations measure consumption, collect and analyze data, improve operational efficiency, and support more reliable and sustainable delivery of essential services.

The company’s portfolio includes smart meters, advanced metering infrastructure, communications networks, sensors, data management systems, and utility software.

Featured Stories

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.